Beware this underrecognised comorbidity in patients with gout

The treatment of gout is considered suboptimal, despite the availability of efficacious urate-lowering therapies.


Some research shows low rates of prescription of the therapy and there’s also evidence from a range of studies that between 10% and 46% of patients with a prescription fail to adhere to their medication.

Gout prevalence is increasing worldwide, particularly in wealthier countries, and the presence of comorbidities adds to the challenges of managing the disease,